I’m not sure that really explains how people get onto hype trains like this in the first place, though. I doubt many people intentionally stake their livelihoods on a solution in search of a problem.

My guess is that it’s more of a recency bias sort of thing: it’s quite easy to assume that a newer way of solving a problem is superior to existing ways simply because it’s new. And also, of course, newfangled things naturally attract investment capital because everyone implicitly knows it’s hard to sell someone a thing they already have and don’t need more of.

It’s not just tech. For example, many people in the USA believe that the ease of getting new drugs approved by the FDA is a reason why the US’s health care system is superior to others, and want to make it even easier to get drugs approved. But research indicates the opposite: within a drug class, newer drugs tend to be less effective and have worse side effects than older ones. But new drugs are definitely much more expensive because their period of government-granted monopoly hasn’t expired yet. And so, contrary to what recency bias leads us to believe, this more conservative approach to drug approval is actually one of the reasons why other countries have better health care outcomes at lower cost.